PDCD1LG2 and neoplasm: In one study using the Panc02 murine pancreatic tumor model, decreased tumor outgrowth rates on day 21 were seen when the animals were treated with PD-L2 blocking antibodies, comparable to that seen with blocking PD-L1 or PD-1 alone [73].